Costs of treating cardiovascular events in Germany: a systematic literature review View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-12

AUTHORS

Tamara Schmid

ABSTRACT

OBJECTIVE: This study aims to systematically evaluate available evidence regarding direct medical costs of treating cardiovascular (CV) events in Germany after 2003 on an individual patient basis and from a payer perspective. The CV events of interest were myocardial infarction (MI), unstable angina, heart failure (HF), stroke, and peripheral artery disease (PAD). METHOD: A systematic literature search was performed in the following databases according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines - Medline, Embase, Centre for Reviews and Dissemination, TIBORDER, and German dissertation database from January 2003 to October 2013. Both observational studies and randomized clinical trials were considered for the review. All values stated in € are inflation adjusted to 2014 € unless stated otherwise. RESULT: This review included 13 articles. For newly occurred MI patients, the average hospitalization costs during the acute phase were reported to be between € 6790 and € 8918 per admission. In the first year after a MI event, direct medical costs were € 13,838-14,792 per patient. Direct medical costs of chronic HF patients were found to be between € 3417 and 5576 per patient per year. Treatment costs increase with disease progression. The average treatment costs for hospitalized PAD in the acute phase were reported to be € 4963 per admission, € 2535 per patient during month 1-6 after the initial hospitalization, € 1601 in month 7-12, and € 1390 in month 13-18. For stroke of all types, total direct medical costs in the 1st year after an event were reported to be € 13,273 per patient. Total direct medical costs during the 1st year after an ischemic stroke event were € 17,399-21,954 per patient, € 6260 in month 13-18, and € 6496 per year in the subsequent 4 years. CONCLUSION: MI, unstable angina, HF, stroke and PAD have a high financial impact on the German health care system. Treatment costs of these diseases are mostly incurred during the acute phase of events and tend to decrease over time. Hospitalization and rehabilitation costs were two major cost drivers. Medication costs was one of the smallest cost component reported. More... »

PAGES

27

Journal

TITLE

Health Economics Review

ISSUE

1

VOLUME

5

Author Affiliations

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13561-015-0063-5

DOI

http://dx.doi.org/10.1186/s13561-015-0063-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1017699661

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26400849


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Amgen (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.420023.7", 
          "name": [
            "Amgen GmbH, Hanauer Str. 1, 80992, Munich, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schmid", 
        "givenName": "Tamara", 
        "id": "sg:person.0664377067.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664377067.00"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.3111/13696998.2012.686464", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003363884"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00103-013-1666-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004483848", 
          "https://doi.org/10.1007/s00103-013-1666-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10389-005-0112-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004728341", 
          "https://doi.org/10.1007/s10389-005-0112-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10389-005-0112-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004728341", 
          "https://doi.org/10.1007/s10389-005-0112-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/11597340-000000000-00000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006697643", 
          "https://doi.org/10.2165/11597340-000000000-00000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00392-009-0081-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013575867", 
          "https://doi.org/10.1007/s00392-009-0081-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00392-009-0081-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013575867", 
          "https://doi.org/10.1007/s00392-009-0081-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00392-009-0081-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013575867", 
          "https://doi.org/10.1007/s00392-009-0081-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijcard.2012.01.099", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014876227"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.03.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021699909"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03320768", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023441201", 
          "https://doi.org/10.1007/bf03320768"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10389-012-0501-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028065906", 
          "https://doi.org/10.1007/s10389-012-0501-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1258/hsmr.2010.010002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029215074"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1258/hsmr.2010.010002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029215074"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10389-011-0420-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031399243", 
          "https://doi.org/10.1007/s10389-011-0420-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hec.2941", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032737385"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03320748", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032878025", 
          "https://doi.org/10.1007/bf03320748"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pmed.1000097", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037575666"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.str.0000217450.21310.90", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043121557"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.str.0000217450.21310.90", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043121557"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hec.1322", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048935191"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.artmed.2004.01.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049526665"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jval.2012.08.981", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052876654"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1024/0040-5930/a000245", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056316897"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0033-1334914", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057281194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-2005-858685", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057442060"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078433934", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-12", 
    "datePublishedReg": "2015-12-01", 
    "description": "OBJECTIVE: This study aims to systematically evaluate available evidence regarding direct medical costs of treating cardiovascular (CV) events in Germany after 2003 on an individual patient basis and from a payer perspective. The CV events of interest were myocardial infarction (MI), unstable angina, heart failure (HF), stroke, and peripheral artery disease (PAD).\nMETHOD: A systematic literature search was performed in the following databases according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines - Medline, Embase, Centre for Reviews and Dissemination, TIBORDER, and German dissertation database from January 2003 to October 2013. Both observational studies and randomized clinical trials were considered for the review. All values stated in \u20ac are inflation adjusted to 2014 \u20ac unless stated otherwise.\nRESULT: This review included 13 articles. For newly occurred MI patients, the average hospitalization costs during the acute phase were reported to be between \u20ac 6790 and \u20ac 8918 per admission. In the first year after a MI event, direct medical costs were \u20ac 13,838-14,792 per patient. Direct medical costs of chronic HF patients were found to be between \u20ac 3417 and 5576 per patient per year. Treatment costs increase with disease progression. The average treatment costs for hospitalized PAD in the acute phase were reported to be \u20ac 4963 per admission, \u20ac 2535 per patient during month 1-6 after the initial hospitalization, \u20ac 1601 in month 7-12, and \u20ac 1390 in month 13-18. For stroke of all types, total direct medical costs in the 1st year after an event were reported to be \u20ac 13,273 per patient. Total direct medical costs during the 1st year after an ischemic stroke event were \u20ac 17,399-21,954 per patient, \u20ac 6260 in month 13-18, and \u20ac 6496 per year in the subsequent 4\u00a0years.\nCONCLUSION: MI, unstable angina, HF, stroke and PAD have a high financial impact on the German health care system. Treatment costs of these diseases are mostly incurred during the acute phase of events and tend to decrease over time. Hospitalization and rehabilitation costs were two major cost drivers. Medication costs was one of the smallest cost component reported.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13561-015-0063-5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1046836", 
        "issn": [
          "2191-1991"
        ], 
        "name": "Health Economics Review", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "name": "Costs of treating cardiovascular events in Germany: a systematic literature review", 
    "pagination": "27", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "54551231eed78f3f7b5ab4eabf44b06b2333be19992045252f7b4ded0a27524b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26400849"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101583209"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13561-015-0063-5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1017699661"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13561-015-0063-5", 
      "https://app.dimensions.ai/details/publication/pub.1017699661"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:10", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000367_0000000367/records_88247_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs13561-015-0063-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13561-015-0063-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13561-015-0063-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13561-015-0063-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13561-015-0063-5'


 

This table displays all metadata directly associated to this object as RDF triples.

141 TRIPLES      21 PREDICATES      51 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13561-015-0063-5 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N76ee722d4c8241a88577e4779d70c4e3
4 schema:citation sg:pub.10.1007/bf03320748
5 sg:pub.10.1007/bf03320768
6 sg:pub.10.1007/s00103-013-1666-9
7 sg:pub.10.1007/s00392-009-0081-6
8 sg:pub.10.1007/s10389-005-0112-3
9 sg:pub.10.1007/s10389-011-0420-8
10 sg:pub.10.1007/s10389-012-0501-3
11 sg:pub.10.2165/11597340-000000000-00000
12 https://app.dimensions.ai/details/publication/pub.1078433934
13 https://doi.org/10.1002/hec.1322
14 https://doi.org/10.1002/hec.2941
15 https://doi.org/10.1016/j.artmed.2004.01.017
16 https://doi.org/10.1016/j.ijcard.2012.01.099
17 https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.03.005
18 https://doi.org/10.1016/j.jval.2012.08.981
19 https://doi.org/10.1024/0040-5930/a000245
20 https://doi.org/10.1055/s-0033-1334914
21 https://doi.org/10.1055/s-2005-858685
22 https://doi.org/10.1161/01.str.0000217450.21310.90
23 https://doi.org/10.1258/hsmr.2010.010002
24 https://doi.org/10.1371/journal.pmed.1000097
25 https://doi.org/10.3111/13696998.2012.686464
26 schema:datePublished 2015-12
27 schema:datePublishedReg 2015-12-01
28 schema:description OBJECTIVE: This study aims to systematically evaluate available evidence regarding direct medical costs of treating cardiovascular (CV) events in Germany after 2003 on an individual patient basis and from a payer perspective. The CV events of interest were myocardial infarction (MI), unstable angina, heart failure (HF), stroke, and peripheral artery disease (PAD). METHOD: A systematic literature search was performed in the following databases according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines - Medline, Embase, Centre for Reviews and Dissemination, TIBORDER, and German dissertation database from January 2003 to October 2013. Both observational studies and randomized clinical trials were considered for the review. All values stated in € are inflation adjusted to 2014 € unless stated otherwise. RESULT: This review included 13 articles. For newly occurred MI patients, the average hospitalization costs during the acute phase were reported to be between € 6790 and € 8918 per admission. In the first year after a MI event, direct medical costs were € 13,838-14,792 per patient. Direct medical costs of chronic HF patients were found to be between € 3417 and 5576 per patient per year. Treatment costs increase with disease progression. The average treatment costs for hospitalized PAD in the acute phase were reported to be € 4963 per admission, € 2535 per patient during month 1-6 after the initial hospitalization, € 1601 in month 7-12, and € 1390 in month 13-18. For stroke of all types, total direct medical costs in the 1st year after an event were reported to be € 13,273 per patient. Total direct medical costs during the 1st year after an ischemic stroke event were € 17,399-21,954 per patient, € 6260 in month 13-18, and € 6496 per year in the subsequent 4 years. CONCLUSION: MI, unstable angina, HF, stroke and PAD have a high financial impact on the German health care system. Treatment costs of these diseases are mostly incurred during the acute phase of events and tend to decrease over time. Hospitalization and rehabilitation costs were two major cost drivers. Medication costs was one of the smallest cost component reported.
29 schema:genre research_article
30 schema:inLanguage en
31 schema:isAccessibleForFree true
32 schema:isPartOf N7f6c96c99f804b72929f3984bea57b91
33 N8d1178f5d71b4379a68eaed63a6c89f3
34 sg:journal.1046836
35 schema:name Costs of treating cardiovascular events in Germany: a systematic literature review
36 schema:pagination 27
37 schema:productId N026f504dce7c4872b0acf7238989f753
38 N2d3b59d0d28b49c48ec9741de00732fd
39 N8075b7ce18324bf4a3950a7766e63cdc
40 N94bd5431d3034766b9e4944c29eef87f
41 Na8e3bb421380473d838f47b874f521ca
42 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017699661
43 https://doi.org/10.1186/s13561-015-0063-5
44 schema:sdDatePublished 2019-04-11T13:10
45 schema:sdLicense https://scigraph.springernature.com/explorer/license/
46 schema:sdPublisher Ne09cdcf61b274b5fa88fc1a50296c43c
47 schema:url http://link.springer.com/10.1186%2Fs13561-015-0063-5
48 sgo:license sg:explorer/license/
49 sgo:sdDataset articles
50 rdf:type schema:ScholarlyArticle
51 N026f504dce7c4872b0acf7238989f753 schema:name doi
52 schema:value 10.1186/s13561-015-0063-5
53 rdf:type schema:PropertyValue
54 N2d3b59d0d28b49c48ec9741de00732fd schema:name nlm_unique_id
55 schema:value 101583209
56 rdf:type schema:PropertyValue
57 N76ee722d4c8241a88577e4779d70c4e3 rdf:first sg:person.0664377067.00
58 rdf:rest rdf:nil
59 N7f6c96c99f804b72929f3984bea57b91 schema:issueNumber 1
60 rdf:type schema:PublicationIssue
61 N8075b7ce18324bf4a3950a7766e63cdc schema:name pubmed_id
62 schema:value 26400849
63 rdf:type schema:PropertyValue
64 N8d1178f5d71b4379a68eaed63a6c89f3 schema:volumeNumber 5
65 rdf:type schema:PublicationVolume
66 N94bd5431d3034766b9e4944c29eef87f schema:name readcube_id
67 schema:value 54551231eed78f3f7b5ab4eabf44b06b2333be19992045252f7b4ded0a27524b
68 rdf:type schema:PropertyValue
69 Na8e3bb421380473d838f47b874f521ca schema:name dimensions_id
70 schema:value pub.1017699661
71 rdf:type schema:PropertyValue
72 Ne09cdcf61b274b5fa88fc1a50296c43c schema:name Springer Nature - SN SciGraph project
73 rdf:type schema:Organization
74 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
75 schema:name Medical and Health Sciences
76 rdf:type schema:DefinedTerm
77 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
78 schema:name Clinical Sciences
79 rdf:type schema:DefinedTerm
80 sg:journal.1046836 schema:issn 2191-1991
81 schema:name Health Economics Review
82 rdf:type schema:Periodical
83 sg:person.0664377067.00 schema:affiliation https://www.grid.ac/institutes/grid.420023.7
84 schema:familyName Schmid
85 schema:givenName Tamara
86 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664377067.00
87 rdf:type schema:Person
88 sg:pub.10.1007/bf03320748 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032878025
89 https://doi.org/10.1007/bf03320748
90 rdf:type schema:CreativeWork
91 sg:pub.10.1007/bf03320768 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023441201
92 https://doi.org/10.1007/bf03320768
93 rdf:type schema:CreativeWork
94 sg:pub.10.1007/s00103-013-1666-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004483848
95 https://doi.org/10.1007/s00103-013-1666-9
96 rdf:type schema:CreativeWork
97 sg:pub.10.1007/s00392-009-0081-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013575867
98 https://doi.org/10.1007/s00392-009-0081-6
99 rdf:type schema:CreativeWork
100 sg:pub.10.1007/s10389-005-0112-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004728341
101 https://doi.org/10.1007/s10389-005-0112-3
102 rdf:type schema:CreativeWork
103 sg:pub.10.1007/s10389-011-0420-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031399243
104 https://doi.org/10.1007/s10389-011-0420-8
105 rdf:type schema:CreativeWork
106 sg:pub.10.1007/s10389-012-0501-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028065906
107 https://doi.org/10.1007/s10389-012-0501-3
108 rdf:type schema:CreativeWork
109 sg:pub.10.2165/11597340-000000000-00000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006697643
110 https://doi.org/10.2165/11597340-000000000-00000
111 rdf:type schema:CreativeWork
112 https://app.dimensions.ai/details/publication/pub.1078433934 schema:CreativeWork
113 https://doi.org/10.1002/hec.1322 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048935191
114 rdf:type schema:CreativeWork
115 https://doi.org/10.1002/hec.2941 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032737385
116 rdf:type schema:CreativeWork
117 https://doi.org/10.1016/j.artmed.2004.01.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049526665
118 rdf:type schema:CreativeWork
119 https://doi.org/10.1016/j.ijcard.2012.01.099 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014876227
120 rdf:type schema:CreativeWork
121 https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.03.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021699909
122 rdf:type schema:CreativeWork
123 https://doi.org/10.1016/j.jval.2012.08.981 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052876654
124 rdf:type schema:CreativeWork
125 https://doi.org/10.1024/0040-5930/a000245 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056316897
126 rdf:type schema:CreativeWork
127 https://doi.org/10.1055/s-0033-1334914 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057281194
128 rdf:type schema:CreativeWork
129 https://doi.org/10.1055/s-2005-858685 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057442060
130 rdf:type schema:CreativeWork
131 https://doi.org/10.1161/01.str.0000217450.21310.90 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043121557
132 rdf:type schema:CreativeWork
133 https://doi.org/10.1258/hsmr.2010.010002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029215074
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1371/journal.pmed.1000097 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037575666
136 rdf:type schema:CreativeWork
137 https://doi.org/10.3111/13696998.2012.686464 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003363884
138 rdf:type schema:CreativeWork
139 https://www.grid.ac/institutes/grid.420023.7 schema:alternateName Amgen (Germany)
140 schema:name Amgen GmbH, Hanauer Str. 1, 80992, Munich, Germany
141 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...